Upper Gwynedd, PA, United States of America

Gary V Borzillo

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary V Borzillo. Retrieved from https://idiyas.com/inventor/gary-v-borzillo-h3ohbp71

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gary V Borzillo

Introduction

Gary V Borzillo is a notable inventor based in Upper Gwynedd, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule inhibitors. His work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Gary V Borzillo holds a patent for a small molecule inhibitor of the JAK family of kinases. This patent discloses JAK inhibitors that exhibit low systemic toxicity. The invention includes methods for treating various disease states, disorders, and conditions mediated by JAK, such as cancers of the stomach and intestinal system, including colorectal cancers and familial adenomatous polyposis. He has 1 patent to his name.

Career Highlights

Gary is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His role at the company allows him to contribute to groundbreaking research and development efforts aimed at improving patient outcomes.

Collaborations

Throughout his career, Gary has collaborated with esteemed colleagues, including Edward F Attiyeh and Kurtis E Bachman. These partnerships have fostered an environment of innovation and shared expertise.

Conclusion

Gary V Borzillo's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to the development of JAK inhibitors highlight the importance of research in addressing complex health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…